CLOs on the Move

Concert Pharmaceuticals

www.concertpharma.com

 
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs. The Company`s approach starts with previously studied compounds, including approved drugs, in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert has a broad pipeline of innovative medicines targeting autoimmune and inflammatory diseases and central nervous systems (CNS) disorders.
  • Number of Employees: 100-250
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details
Jeffrey Munsie
 Chief Legal Officer Profile

Similar Companies

illumiPure

illumiPure’s patented Air Guardian and CleanWhite product solutions provide continuous and powerful disinfection to safely eradicate surface and air pathogens, as well as viruses, including SARS-CoV-2, the virus that causes COVID-19, while continuously...

Organon

Organon is a West Orange, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Global CINRG

Global CINRG is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HepQuant

HepQuant is a Aurora, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Processo Partners, In

Processo Partners, In is a Miami, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.